Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Prednisolone
Drug ID BADD_D01831
Description Prednisolone is a glucocorticoid similar to [cortisol] used for its anti-inflammatory, immunosuppressive, anti-neoplastic, and vasoconstrictive effects.[A187463] Prednisolone was granted FDA approval on 21 June 1955.[L9431]
Indications and Usage For the treatment of primary or secondary adrenocortical insufficiency, such as congenital adrenal hyperplasia, thyroiditis. Also used to treat psoriatic arthritis, rheumatoid arthritis, ankylosing spondylitis, bursitis, acute gouty arthritis and epicondylitis. Also indicated for treatment of systemic lupus erythematosus, pemphigus and acute rhematic carditis. Can be used in the treatment of leukemias, lymphomas, thrombocytopenia purpura and autoimmune hemolytic anemia. Can be used to treat celiac disease, insulin resistance, ulcerative colitis and liver disorders.
Marketing Status Prescription; Discontinued
ATC Code A07EA01; C05AA04; D07AA03; D07XA02; H02AB06; R01AD02; S01BA04; S01CB02; S02BA03; S03BA02
DrugBank ID DB00860
KEGG ID D00472
MeSH ID D011239
PubChem ID 5755
TTD Drug ID D0D1SG
NDC Product Code 0395-8164; 51927-0197; 22552-0052; 0527-5406; 82298-104; 50383-042; 64958-0097; 60592-911; 50090-0655; 63187-466; 65089-0038; 67296-1656; 23594-505; 51927-1148; 61919-291; 51927-0234; 57582-004; 38779-0150; 82298-106; 82298-105; 68788-9096; 60722-3001; 73534-505; 49452-5980
Synonyms Prednisolone | Predate | Predonine | Di-Adreson-F | Di Adreson F | DiAdresonF
Chemical Information
Molecular Formula C21H28O5
CAS Registry Number 50-24-8
SMILES CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
ApoptosisDNA topoisomerase 1P11387T098261374671; 1333943; 1333822; 1279323; 1338332; 1649059; 1997159; 1596908; 8383887; 8601414; 7596166; 8227159; 7641180; 10536167; 8319228; 14504478; 1319346; 1540962; 2168279; 7508535
Metabolic disorderCatenin beta-1P35222T8279526318657
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Intracranial pressure increased17.07.02.002--Not Available
Intraocular pressure increased13.07.04.002--Not Available
Iridocyclitis06.04.03.001--Not Available
Keratitis06.04.02.002--
Leukoderma23.05.02.001--Not Available
Loss of consciousness17.02.04.004--Not Available
Malaise08.01.01.003--
Meningitis17.06.03.001; 11.01.03.001--
Menstruation irregular05.05.01.008; 21.01.01.005--
Monoplegia17.01.04.003--Not Available
Mood swings19.04.03.001--Not Available
Muscle disorder15.05.03.014--Not Available
Muscular weakness17.05.03.005; 15.05.06.001--
Mydriasis17.02.11.003; 06.05.03.004--Not Available
Myocardial infarction24.04.04.009; 02.02.02.007--
Myocardial rupture12.01.11.002; 02.04.02.002--Not Available
Myopathy15.05.05.001--Not Available
Nausea07.01.07.001--
Neuritis17.09.03.001--Not Available
Neuropathy peripheral17.09.03.003--Not Available
Nitrogen balance negative13.13.01.010--Not Available
Oedema14.05.06.010; 08.01.07.006--Not Available
Optic neuritis17.04.05.001; 06.04.08.002; 10.04.10.002--Not Available
Osteoarthritis15.01.04.001--Not Available
Osteonecrosis24.04.05.004; 15.02.04.007--
Osteoporosis15.02.03.002; 14.04.04.002--
Pain08.01.08.004--
Pancreatitis07.18.01.001--
Pancreatitis haemorrhagic07.18.01.003--Not Available
Papilloedema24.03.07.001; 17.07.02.004; 06.09.02.002--
The 3th Page    First    Pre   3 4 5    Next   Last    Total 5 Pages